Skip to main content
OpenTrials
Completed

NCT Number: NCT00918151

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea

This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, and complications in diabetic subjects in Asia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Autoimmune Diseases Diabetes Mellitus Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul, 137-920, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diabetic patients registered in the particular centre for more than 12 months.
  • Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit.
  • Patients willing to sign informed consent form.

Exclusion criteria

  • Repetition of any patient as patients should not be included twice for any reason.
  • Unwilling to participate or unable to comply with protocol requirements.

Treatment and study plan

No treatment given

Other

Subject will only fill out a questionaire when entering the observational study

Primary outcomes

  1. Mean age of onset of type 1 and type 2 diabetes mellitus, respectively

    Time frame: at baseline visit/study start

  2. Mean duration of treatment of type 2 diabetes mellitus.

    Time frame: at baseline visit/study start

  3. Percentage of patients on insulin and Oral Anti-Diabetics Drugs (OADs) therapy, respectively

    Time frame: at baseline visit/study start

  4. Mean duration of diabetes in type 1 and type 2 diabetic patients respectively

    Time frame: at baseline visit/study start

  5. Mean FPG (fasting plasma glucose),PPG (post prandial glucose) and HbA1c of diabetic patients.

    Time frame: at baseline visit/study start

  6. Percentage of diabetic patients with HbA1c target below 7.0% and below 6.5%, respectively

    Time frame: at baseline visit/study start

  7. Percentage of diabetic patients having dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications, respectively

    Time frame: at baseline visit/study start

Secondary outcomes

  1. Patients' perception will be analysed through patient questionnaire measuring psychological well-being, quality of life and patients' compliant to treatment

    Time frame: at baseline visit/study start

  2. Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about: HbA1c test and its goal, anti-diabetic treatment, barriers towards optimum diabetes control

    Time frame: at baseline visit/study start

  3. Duration of diabetes associated with highest number of diabetic complications

    Time frame: at baseline visit/study start

  4. Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy)

    Time frame: at baseline visit/study start

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Official study title

DiabCare Asia 2008 (Korea): A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Asia

Acronym: DiabCare Asia

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
Jun 11, 2009
Registry last updated
Nov 2, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.